LEFLUNOMIDE SZ leflunomide 100mg tablet blister pack

Active ingredient:

leflunomide, Quantity: 100 mg

Available from:

Southern Cross Pharma Pty Ltd

INN (International Name):

Leflunomide

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: microcrystalline cellulose; povidone; colloidal anhydrous silica; crospovidone; maize starch; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; macrogol 4000

Administration route:

Oral

Units in package:

3 tablet

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Treatment of active rheumatoid arthritis. The combined use of leflunomide with other disease modifying antirheumatic drugs (DMARDs) has not been adequately studied (see Precautions).

Product summary:

Visual Identification: White, oblong biconvex tablets with a scoreline on one side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2014-04-02